Real-World Outcomes of Ixazomib in the Treatment of Multiple Myeloma from a Single Center in China

被引：0
|
作者：
Sui, Weiwei [1 ,2 ]
An, Gang [3 ]
Deng, Shuhui [4 ,5 ]
Xu, Yan [4 ,5 ]
Hao, Mu [6 ,7 ]
Fu Mingwei [6 ,7 ]
Wang, Tingyu [6 ,7 ]
Yi, Shuhua [4 ,5 ]
Zhao, Yaozhong [8 ,9 ,10 ]
Zou, Dehui [4 ,5 ]
Li, Zengjun [11 ]
Qiu, Lugui [6 ,7 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Lymphoma & Myeloma Ctr, State Key Lab Expt Hematol, Tianjin, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Lymphoma & Myeloma Ctr, State Key Lab Expt Hematol, Tianjin, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China
[4] Chinese Acad Med Sci, Inst Hematol, Tianjin, Peoples R China
[5] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China
[6] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China
[7] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin, Peoples R China
[8] Chinese Acad Med Sci, Hematol Blood Dis Hosp, Tianji, Tianjing, Peoples R China
[9] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, State Key Lab Expt Hematol, Tianjin, Peoples R China
[10] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin, Peoples R China
[11] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China
来源：
BLOOD | 2019年 / 134卷
关键词：
Real-world; Ixazomib; multiple myeloma;
D O I：
10.1182/blood-2019-126718
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5581
引用
收藏
页数：3
相关论文
共 50 条
  • [41] REAL-WORLD MANAGEMENT AND OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA IN ROMANIA AND POLAND
    Dytfeld, D.
    Coriu, D.
    Fink, L.
    Hemetsberger, M.
    Bjorklof, K.
    Toka, K. S.
    Gatta, F.
    Niepel, D.
    VALUE IN HEALTH, 2017, 20 (09) : A459 - A460
  • [42] Real-World Clinical Outcomes in Patients With Multiple Myeloma Administered With Elotuzumab-Based Treatment
    Kikuchi, Taku
    Tsukada, Nobuhiro
    Oda, Yuki
    Nomura-Yogo, Moe
    Takei, Tomomi
    Sato, Kota
    Ogura, Mizuki
    Abe, Yu
    Suzuki, Kenshi
    Ishida, Tadao
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [43] Real-world multiple myeloma front-line treatment and outcomes by transplant in the United States
    Richter, Joshua
    Pan, Darren
    Salinardi, Taylor
    Rice, Megan S.
    EJHAEM, 2023, 4 (04): : 984 - 994
  • [44] Real-World Outcomes for the Treatment of Relapsed/Refractory Multiple Myeloma With Daratumumab: A Systematic Literature Review
    Gros Otero, B.
    Gungor, G.
    Gruppe, T. L.
    Wan, M.
    Jenkins, C.
    Helme, K.
    VALUE IN HEALTH, 2022, 25 (12) : S494 - S494
  • [45] Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma
    Bruno, Amanda S.
    Willson, Jenny L.
    Opalinska, Joanna M.
    Nelson, Jeanenne J.
    Lunacsek, Orsolya E.
    Stafkey-Mailey, Dana R.
    Willey, Joanne P.
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 1017 - 1025
  • [46] Real-world outcomes of venetoclax refractory multiple myeloma patients.
    Maples, Kathryn T.
    Kaufman, Jonathan L.
    Gupta, Vikas Anand
    Joseph, Nisha
    Heffner, Leonard T.
    Hofmeister, Craig C.
    Dhodapkar, Madhav, V
    Matulis, Shannon M.
    Boise, Lawrence
    Lonial, Sagar
    Nooka, Ajay K.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [47] Current real-world treatment patterns and outcomes in patients with relapsed/refractory multiple myeloma.
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeanenne Joy
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne P.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] Real-world clinical outcomes in patients with multiple myeloma treated with isatuximab after daratumumab treatment
    Taku Kikuchi
    Nobuhiro Tsukada
    Moe Nomura
    Yuki Kasuya
    Yuki Oda
    Kota Sato
    Tomomi Takei
    Mizuki Ogura
    Yu Abe
    Kenshi Suzuki
    Tadao Ishida
    Annals of Hematology, 2023, 102 : 1477 - 1483
  • [49] Real-world clinical outcomes in patients with multiple myeloma treated with isatuximab after daratumumab treatment
    Kikuchi, Taku
    Tsukada, Nobuhiro
    Nomura, Moe
    Kasuya, Yuki
    Oda, Yuki
    Sato, Kota
    Takei, Tomomi
    Ogura, Mizuki
    Abe, Yu
    Suzuki, Kenshi
    Ishida, Tadao
    ANNALS OF HEMATOLOGY, 2023, 102 (06) : 1477 - 1483
  • [50] Real-World Multiple Myeloma Front-Line Treatment and Outcomes By Transplant in the United States
    Richter, Joshua
    Pan, Darren
    Salinardi, Taylor
    Rice, Megan S.
    BLOOD, 2022, 140 : 7187 - 7188
12345